
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. GunjanRead More
The cost of developing a new drug roughly doubles everyRead More
In medicine, a Biomarker is a biological indicator, which canRead More
Innoplexus will now be a part of NVIDIA Inception Program. A program that is designed to nurture dedicated and exceptional startups who are revolutionizing industries with advances in AI and data science. The Inception Program helps during different stages of product development, prototyping, and deployment.
The formal confirmation came on May 23rd, 2018. It all started when our Co-founder and CTO, Gaurav Tripathi explained about Innoplexus, our products and what we are doing in Deep Learning to Inception program coordinators at GPU Technology Conference in San Francisco. The program owners liked our idea, especially the way we are using Deep Learning to revolutionize the pharmaceutical industry.
After receiving the confirmation of this virtual accelerator program, Gaurav said, “I have been a huge NVIDIA fan from my gaming days (once upon a time in history, I do used to play) and my PC assembling days (used to sell assembled PCs in IITB campus for some quick money). I have seen it grow from a ‘graphic card’ company to the AI giant that it is now and have been looking for a chance to do something with them or get associated in some way.”
Innoplexus will now get a custom set of ongoing benefits like access to NVIDIA global network and the Deep Learning Institute as well as GPU hardware discounts,and early access to state-of-the-art technology. “This is a very supportive opportunity on our way to an European Artificial Intelligence-Champion”, summarizes Gaurav.
The original article was published on NVIDIA.
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Bad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took…
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston,…
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany,…